International Clinical Trial: Does intermittent treatment in pregnancy with sulfadoxine-pyrimethamine prevent small vulnerable newborns through non-malarial effects? - A randomised controlled trial

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001191381) titled 'Does intermittent treatment in pregnancy with sulfadoxine-pyrimethamine prevent small vulnerable newborns through non-malarial effects? - A randomised controlled trial' on Sept. 24.

Study Type: Interventional

Study Design: Purpose: Prevention Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel Type of endpoint: Safety/efficacy

Primary Sponsor: Menzies School of Health Research

Condition: Small vulnerable newborn Small-for-gestational age at birth Preterm birth Small vulnerable newborn Small-for-gestational age at birth Preterm birth Reproductive Health and Childbi...